Leukotriene modifiers: What place in asthma management?

Journal of Respiratory Diseases

Volumn 19, Issue 3, 1998, Pages 245-261

  Gross, Nicholas J ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; ZAFIRLUKAST; ZILEUTON;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATATION; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; HUMAN; LIVER TOXICITY; PRACTICE GUIDELINE; SYSTEMIC VASCULITIS;

EID: 0031917881     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Smith LJ. Leukotrienes in asthma, the potential therapeutic role of antileukotriene agents. Arch Intern Med. 1996;156:2181-2189.
2. Strek ME. Leukotriene receptor antagonists and synthesis inhibitors in asthma. In: Left AR, ed. Pulmonary and Critical Care Pharmacology and Therapeutics. New York: McGraw-Hill Inc; 1996:649-662.